Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,067 public trials 1,185 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Active, not recruiting

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

NCT03604198

Conditions
ACTH Syndrome, Ectopic, Adenocarcinoma, Adrenal Cortex Diseases, +30 more
Locations
  • Site 49 Phoenix, Arizona, United States
  • Site 35 Stanford, California, United States
  • Site 39 Torrance, California, United States
  • Site 50 Miami, Florida, United States
View all 48 locations
View Trial Details
Active, not recruiting

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

NCT02978625

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Anaplastic Large Cell Lymphoma, ALK-Positive, +86 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
View all 36 locations
View Trial Details
Active, not recruiting

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

NCT06399757

Conditions
Adenocarcinoma, Adenocarcinoma, Mucinous, Adnexal Diseases, +46 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Active, not recruiting

SIRT With Tremelimumab and Durvalumab for Resectable HCC

NCT05701488

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

NCT01575548

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 579 locations
View Trial Details
Active, not recruiting

A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma

NCT05805501

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC Irvine Medical Center Orange, California, United States
  • Emory University Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View all 43 locations
View Trial Details
Active, not recruiting

A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation

NCT04280081

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The First Affiated Hospital Of Guangzhou Medical University Guangzhou, Guangdong, China
  • Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View all 13 locations
View Trial Details

Related conditions